4D. HIV&AIDS Session: Discovery & translational science: Vaccines and diagnostics
Tracks
| Monday, September 14, 2026 |
| 4:00 PM - 5:30 PM |
Speaker
Mr Yuanhao Chen
Phd Candidate
University of Melbourne
mRNA vaccine candidates expressing stabilized Env trimers, some presented on HTLV-1 virus-like particles, elicit broad and potent neutralizing antibodies
Biography
Yuanhao Chen is a PhD candidate at the University of Melbourne. His research focuses on the development of an mRNA-based Human T-cell lymphotropic virus type-1 (HTLV-1) virus-like particle (VLP) vaccine as a vaccine candidate to prevent HTLV-1c transmission and infection.
Mrs Angelique Levert
Research Scientist
St Vincent's Centre For Applied Medical Research
A Novel Long-RNA HIV Drug Resistance Test Enabling Capsid (Lenacapavir) Resistance Detection, Optimised For Sanger And Nanopore Sequencing
Biography
Angelique Levert is a Research Scientist in the HIV Diagnostics Laboratory, at St Vincent’s Centre for Applied Medical Research. Her work focuses on HIV molecular diagnostics, drug resistance testing, and the development of sequencing-based assays to support clinical care and translational research.
Melissa Barrow
Research Fellow
University Of Melbourne
Dr Eloise Williams
Clinical Microbiologist and Infectious Diseases Physician
Victorian Infectious Diseases Reference Laboratory
PERFORMANCE OF THE GEENIUS HIV 1/2 CONFIRMATORY ASSAY FOR DIAGNOSIS OF HIV IN THE AUSTRALIAN SETTING
Biography
Dr Eloise Williams is a Clinical Microbiologist, Infectious Diseases Physician and Clinician Researcher with appointments at the Victorian Infectious Diseases Reference Laboratory, Austin Health and University of Melbourne at the Peter Doherty Institute for Infection and Immunity. Her interests include blood borne viruses, sexually transmitted infections and translational diagnostics.